chr22-38726085-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004286.5(GTPBP1):c.1153C>T(p.Pro385Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000124 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004286.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTPBP1 | ENST00000216044.10 | c.1153C>T | p.Pro385Ser | missense_variant | Exon 7 of 12 | 1 | NM_004286.5 | ENSP00000216044.5 | ||
GTPBP1 | ENST00000460605.1 | n.345C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 3 | |||||
GTPBP1 | ENST00000475959.1 | n.279C>T | non_coding_transcript_exon_variant | Exon 1 of 2 | 2 | |||||
GTPBP1 | ENST00000458073.5 | c.-221C>T | upstream_gene_variant | 5 | ENSP00000388147.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000596 AC: 15AN: 251486Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135920
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461768Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727198
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152158Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1153C>T (p.P385S) alteration is located in exon 7 (coding exon 7) of the GTPBP1 gene. This alteration results from a C to T substitution at nucleotide position 1153, causing the proline (P) at amino acid position 385 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at